The new Rutgers REACH hub will identify innovative health-related technologies by using the expertise of the National Cancer Institute-funded Rutgers Cancer Institute, RITMS, and the New Jersey Center for Biomaterials (NJCBM). These technologies will be evaluated for commercialization feasibility, especially as they relate to providing precision therapy to tackle an unmet need created by the heterogeneity of disease development and response to treatment. Addressing such needs can provide assets tailored to patients’ therapeutic responses that ultimately improve health. To learn more about the hub.
Home / News / From NJBIZ.com: Rutgers ROI Program to integrate strengths in biomedical sciences, expertise in research commercialization
Recent Posts
- Join Princeton Precision Health Seminar Series on 3/21 in Princeton
- Exercise May Lower Your Dementia Risk—Here’s How It Works.
- How New Therapies Are Revolutionizing the Treatment of Juvenile Idiopathic Arthritis.
- NJIT’s Grace Hopper AI Research Institute Launches with $1 Million in Research Proposals.
- Scientists Explain ‘Ozempic Blindness,’ Link Between Sudden Vision Loss and Weight Loss Drugs.
Categories
- Community (2,169)
- Covid (982)
- CTO Events (6)
- News (2,770)
- Pilots (21)